Suzette Glasner-Edwards, Ph.D.

Transcription

1 California Medical Evaluators Wilshire Blvd. Suite 340 Los Angeles, CA Ph: Fx: EDUCATION Post-Doctoral Fellowship Suzette Glasner-Edwards, Ph.D. Veterans Healthcare Administration, San Diego ( ) Associate Investigator Project: Integrated Intervention for Substance Abusers with Depressive Disorders Internship University of California at San Diego ( ) Major Rotations: Alcohol/Drug Treatment Program, Veterans Administration San Diego Outpatient Psychiatry, UCSD School of Medicine Graduate University of Minnesota at Twin Cities ( ) Degree: M.A., Psychology (May, 2000) Degree: Ph.D., Clinical Psychology (September, 2002) Minor: Psychopharmacology Undergraduate University of California at Los Angeles ( ) Major: Psychology Degree: B.A. (with Highest Honors) LICENSURE State of California, Licensed Psychologist (June, 2004), current (#PSY 19704) PROFESSIONAL EXPERIENCE University of California, Los Angeles (2007-present) Associate Professor Department of Psychiatry and Biobehavioral Sciences Semel Institute of Neuroscience & Behavior, David Geffen School of Medicine 1

2 Private Practice (2007-present) San Vicente Blvd., Suite 280 Los Angeles, CA Cedars-Sinai Medical Center, Department of Psychiatry ( ) Clinical Director Dual Diagnosis Program PROFESSIONAL ACTIVITIES Member, National Cancer Institute, Special Emphasis Contract Review Panel, Small Business Innovation Research, Validation of Mobile Technologies for Clinical Assessment, Monitoring, and Intervention (2016) Program Co-Chair, Division of Addictions, American Psychological Association Annual Meeting (2014, 2015) Member, National Institute on Drug Abuse Special Emphasis Panel, Integration of Infectious Diseases and Substance Abuse Intervention Services for Individuals Living with HIV (2015) Member, NIDA Special Emphasis Panel, Multi-Site Clinical Trials ( ) Member, NIDA Special Emphasis Panel, AIDS Science Track Award for Research Transition (A-START) (2014) Member, National Institute on Allergy and Infectious Diseases Small Business Innovation Research Review Panel (2014) Chair, NIDA Special Emphasis Panel, Multi-Site Clinical Trials (2014) Reviewer, AIDS and Behavior Member, Editorial Board, Journal of Psychoactive Drugs Member, Editorial Board, Journal of Addiction Research & Therapy Reviewer, Annals of Internal Medicine Reviewer, Medical Care Reviewer, Addiction Reviewer, Archives of General Psychiatry Reviewer, Journal of Studies on Alcohol and Drugs Reviewer, Journal of Substance Abuse Treatment Reviewer, American Journal on Addictions Reviewer, Journal of Dual Diagnosis Reviewer, Progress in Neuro-psychopharmacology and Biological Psychiatry Reviewer, Psychiatry Research 2

3 Reviewer, Drug and Alcohol Dependence Reviewer, Drug and Alcohol Review Reviewer, Journal of Experimental Psychology Reviewer, European Journal of Psychiatry Grant Reviewer, Veterans Affairs Medical Research Service Grant Reviewer, Swiss National Science Foundation American Psychological Association (Member, 2009-present) American Psychological Association, Division 50 (Addictions) (Member, present) College on Problems of Drug Dependence (Associate Member, 2009-present) Psi Chi Honors Society (Full Member, 1998 to present) Sigma Xi National Honors Society (Elected, Associate Member, 2002 to present) HONORS and AWARDS Recipient of Early Investigators Career Award, NIDA/NIAAA for the American Psychological Association Meeting (August, 2010) Recipient of a travel award from NIAAA for the Addiction Health Services Research Conference (October, 2009) Recipient of a travel grant from Friends of the Semel Institute, UCLA (June, 2008) Recipient of a "Harrison Gough Travel Award" from the University of Minnesota, Department of Psychology (July, 2000) Recipient of a "Harrison Gough Research Award" from the University of Minnesota, Dept. of Psychology (April, 1999) Recipient of a Graduate Block Fellowship, University of Minnesota ( ) Awarded Honorable Mention by the Ford Foundation (1999) Recipient of the "John Seward Memorial Award" from UCLA Dept. of Psychology for outstanding undergraduate research in learning, behavior and motivation (June, 1998) Awarded Highest Honors from the Dept. of Psychology at UCLA (June, 1998) Awarded Honorable Mention by the National Science Foundation (1998) Awarded Honorable Mention by the Ford Foundation (1998) 3

4 RESEARCH GRANTS AND FELLOWSHIPS RECEIVED Principal Investigator, National Institute on Drug Abuse, #R56 DA036718, Cost- Effectiveness and Efficacy of Computerized Therapy for Depression and Drug Use ( ) Principal Investigator, Clinical Trial Planning Grant, National Institute on Alcohol Abuse and Alcoholism, #1R34AA033196, Cell Phone Technology Targeting ART & Naltrexone Adherence and Alcohol Use ( ) Principal Investigator, Research Award, National Institute on Drug Abuse, #1R01DA , SBIRT for Substance Abuse in Mental Health Treatment Settings ( ) Principal Investigator, Clinical Trial Planning Grant, National Institute on Drug Abuse, #1R34DA , Cell Phone Technology Targeting Antiretroviral Therapy and Suboxone Adherence and Injection Drug Use ( ) Principal Investigator, Exploratory and Developmental Grant, National Institute on Drug Abuse, #1R21DA , Mindfulness Based Relapse Prevention for Stimulant Users ( ) Principal Investigator, Career Development Award, National Institute on Drug Abuse, #1K23DA , Motivational Therapy for Depressed Stimulant Users ( ) Principal Investigator, Investigator-Initiated Grant, Eli Lilly & Company, #F1J-US- X046, Duloxetine for Depressed Stimulant Users ( ) Co-Principal Investigator, Department of Veterans Affairs, Medical Research Service, Merit Award Integrated Intervention for Depressed Substance Users ( ), PI: Sandra A. Brown, Ph.D. "Associate Investigator Award," Department of Veterans Affairs, Medical Research Service ( ) Individual National Research Service Award, National Institute on Alcohol Abuse and Alcoholism #AA ( ) National Institute of Mental Health Predoctoral Traineeship, Neurobehavioral Training Grant # MH , University of Minnesota ( ) LECTURE AND OTHER INVITED PRESENTATIONS 4

5 Lecture, LA. Care, Pain Management in the Primary Care Setting Conference (April, 2016). Cognitive Behavioral Therapy for the Addicted Patient with Chronic Pain. Lecture, L.A. Care, Behavioral Health Treatments in Primary Care Settings Conference (February, 2016). Screening and Brief Intervention Approaches to Substance Use Disorders. Lecture, UCLA Counseling and Psychological Services (January, 2016). Evidence- Based Treatments for Addictions and Co-Occurring Mental Illness for Young Adults. Lecture, UCLA Addiction Medicine Clinic (September, 2015). Treating Addiction With CBT. Symposium Chair, American Psychological Association (August, 2015). HIV and Substance Use: Using Technology to Understand and Intervene Upon Risk Behaviors. Lecture, UCLA School of Nursing, N260 Secondary Prevention Course (April, 2015). Addiction Prevention, Diagnosis, and Treatment: Lessons Learned from Clinical Science. Lecture, UCLA Counseling and Psychological Services (April, 2015). Mindfulness and Motivationally Based Intervention Techniques for Young Adults with Substance Use Disorders. Lecture, UCLA Integrated Substance Abuse Programs, Pre/Post-Doctoral Seminar (January, 2015). Clinical Research on Emerging Evidence-Based Practices for Addiction: Current State of the Art. Psychiatry Grand Rounds, Harbor UCLA (November, 2014). Evidence Based Psychosocial Treatments for Addictions: An Overview of Treatments That Work. Plenary session, UCLA Annual Review of Psychiatry and Psychopharmacology (November, 2014). Behavioral Management Strategies in the Treatment of Addiction. Plenary session, California Society of Addiction Medicine (September, 2014). Beyond Medications: Evidence-Based Addiction Behavioral Interventions. Lecture, UCLA Seminars in Addiction Psychiatry Course (May, 2014). Technology Based Treatment for Addictions and HIV. Lecture, UCLA School of Nursing (April, 2014), N260 Secondary Prevention Course. Epidemiology and Evidence-Based Treatments for Substance Use Disorders. 5

6 Lecture, Clare Foundation (March, 2014). Mindfulness Based Relapse Prevention As a Component of Addiction Treatment. Lecture, UCLA PGY3 Psychiatry Residency Series (February, 2014). Motivational Interviewing: Promoting Insight and Behavior Change. Lecture, UCLA Student Psychological Services (January, 2014). Integrating CBT, MET and Mindfulness in Treatment of College Students With Substance Use Disorders. Lecture, UCLA s 18 th Annual Review of Psychiatry and Psychopharmacology October, 2013). The Importance of Behavioral Management in Treating Addiction. Lecture, Los Angeles County Department of Public Health Substance Abuse Prevention and Control, Meeting on Innovations in in substance use disorders treatment: the use of Smartphone technology and text messaging for treatment engagement and recovery support. (September, 2013). Development of a CBT- Based Text Messaging Intervention for HIV+ Opioid Users. Symposium Chair, American Psychological Association (August, 2013). Technology Based Interventions for Substance Use Disorders and Related Conditions. Lecture, UCLA Seminars in Addiction Psychiatry Course (May, 2013). Advances in Psychosocial Interventions for Substance Users With Psychiatric and Medical Comorbidities. Lecture, UCLA School of Nursing, N260 Secondary Prevention Course (May, 2013). Advances in Understanding and Treating Addiction. Lecture, UCLA PGY3 Psychiatry Residency Series (April, 2013). CBT and Mindfulness Based Relapse Prevention: Emerging Strategies in the Treatment of Substance Use Disorders. Lecture, NIDA Clinical Trials Network Dissemination Conference (February, 2013). Behavioral Interventions for Addictions and Co-Occurring Disorders. Lecture, UCLA Addiction Medicine Clinic (January, 2013). Psychotherapy Techniques for Engaging Patients With Substance Use Disorders. Lecture, 7 th Annual Drug Abuse Research Day, Charles R. Drew University of Medicine and Science (August, 2012). Psychosocial Interventions for Stimulant Dependent Adults. 6

7 Lecture, Detoxification and Pain Management Training, Pacific Southwest Addiction Technology Transfer Center (July, 2012). The Cycle of Chronic Pain and Addiction. Late Breaking News Session, 74 th Annual Meeting of the College on Problems of Drug Dependence (June, 2012). Mindfulness Based Relapse Prevention Reduces Negative Affect and Stress Reactivity Among Stimulant Dependent Adults. Symposium on Addiction and Stress, 74 th Annual Meeting of the College on Problems of Drug Dependence (June, 2012). Association of Post-Traumatic Stress Disorder With Post-Treatment Outcomes of Methamphetamine Dependent Adults. Lecture, Los Angeles County Department of Mental Health (June, 2012). Diagnosis and Management of Psychosis in Methamphetamine-Dependent Patients. Lecture, UCLA Integrated Substance Abuse Programs, Pre/Post-Doctoral Seminar (June, 2012). Current Trends in Behavioral Interventions Research for Co- Occurring Disorders. Lecture, UCLA Seminars in Addiction Psychiatry Course (May, 2012). Mindfulness Based Relapse Prevention for Stimulant Dependence. Lecture, UCLA PGY3 Psychiatry Residency Series (January, 2012). Relapse Prevention and Motivational Psychotherapies for Addictions. Lecture, UCLA PGY3 Psychiatry Residency Series (January, 2011). Outpatient Substance Abuse: Advances in Alcohol Research and Treatment. Lecture, UCLA Addiction Medicine Clinic (January, 2011). Cognitive Behavioral Therapy for Substance Use Disorders. Symposium, Joint Meeting on Adolescent Treatment Effectiveness (December, 2010). Tailoring Mindfulness Therapies for Adolescents. Lecture, UCLA Integrated Substance Abuse Programs, Pre/Post-Doctoral Seminar (October, 2010). Evidence-Based Care for Substance Abusers: Review and Recommendations for Public Policy. Lecture, Professional Psychology Seminars (September, 2010). Evidence-Based Behavioral Interventions for Addiction. Symposium Chair, American Psychological Association (August, 2010). Optimizing Treatment of Substance Users With Psychiatric Comorbidity. Lecture, Center for Advancing Longitudinal Drug Abuse Research (August, 2010). Psychosocial Interventions for Substance Use Disorders. 7

8 Discussant, Translational Research in Methamphetamine Addiction Conference (July, 2010). Therapy for Methamphetamine Addiction. Lecture, UCLA Integrated Substance Abuse Programs, Pre/Post-Doctoral Seminar (May, 2010). Addiction Treatment: State of the Art Regarding Treatment Effectiveness. Lecture, UCLA Addiction Medicine Clinic (April, 2010). Cognitive and Motivational Interventions for Substance Users Symposium on Drugs and Crime, International Society for the Study of Drug Policy, 4 th Annual Meeting (March, 2010). Evidence-Based Practices in Addiction Treatment: Considerations for Implementation and Public Policy UCLA Addiction Consortium Data Blitz (January, 2010). Clinical Course and Outcomes of Methamphetamine Dependent Adults With Psychiatric Comorbidity Workshop on Methamphetamine Use Disorders: Associated Symptoms and Treatment Options, American Academy of Addiction Psychiatry, 20 th Annual Meeting (December, 2009). Psychiatric Comorbidity Among Methamphetamine Users: Assocation With Posttreatment Outcomes Lecture, UCLA Seminars in Addiction Psychiatry Course (December, 2009). Psychiatric Illness Among Methamphetamine Dependent Adults Lecture, Substance Abuse Research Consortium Meeting (September, 2009). Evidence-Based Practices in Addiction Treatment: An Overview Lecture, UCLA Addiction Medicine Clinic (August, 2008). Motivating Clients for Change in Outpatient Care Lecture, UCLA Student Psychological Services (October, 2008). Engaging College Students with Substance Use Disorders in Treatment Lecture, UCLA s 12 th Annual Review of Psychiatry and Psychopharmacology (October, 2007). Cognitive-Motivational Therapy Lecture, UCLA Integrated Substance Abuse Programs, Scientific Presentation Series (October, 2007). The Methamphetamine Treatment Project and 3-Year Follow-Up Panelist, Sierra Tucson and Matrix Professional Development Series (September, 2007). Diagnosis and Treatment Options for Substance Abuse Disorders in the Private Practice Setting 8

9 Lecture, UCLA Center for East-West Medicine (August, 2007). Treatment of Methamphetamine Users: A Role for Alternative Medicine Symposium on Motivational Counseling, APA, 114 th Convention (August, 2006) Motivational Interventions for Substance Users With Psychiatric Comorbidity Symposium, Crystal Methamphetamine, Cedars-Sinai Medical Center (June, 2006) Using Motivational Interventions in Primary Care Panelist, Cedars-Sinai Medical Center, Dept of Cardiology (February, 2006) Addictions and My Heart. Lecture in Neuroscience Seminar, University of Minnesota (2000) The Neurochemical Basis of Acute and Chronic Ethanol Reinforcement. Research Day, University of Minnesota (2000) The Motivational Control of Alcohol- Seeking Behavior. Lecture in Psychopharmacology Seminar at University of Minnesota (1999) The Effects of Stress and Ethanol on Corticosterone and Free Fatty Acids. Research Day, University of Minnesota (1999) The Relation of Personality to Alcohol Use Among Subjects With Panic Disorder. UCLA Undergraduate Psychology Research Conference (1997) Paper presentation: The Role of Incentive Learning in Instrumental Outcome Revaluation by Sensory-Specific Satiety. UCLA Undergraduate Psychology Research Conference (1997) Paper presentation: The Relation of Acceptance and Problem Solving to Dyadic Satisfaction: A Correlational Study. BIBILIOGRAPHY RESEARCH PAPERS (PEER REVIEWED) 1. Glasner, S.V., Overmier, J.B., & Balleine, B.W. (2005). The role of Pavlovian cues in alcohol-seeking behavior in alcohol-dependent and nondependent rats. Journal of Studies on Alcohol, 66(1): Tate, S.R., Brown, S.A., Glasner, S.V., Unrod, M., & McQuaid, J. (2006). Stress and temptation in substance relapse: additive or synergistic effects. Addiction Research & Theory, 14(3): Brown, S.A., Glasner-Edwards, S.V., Tate, S.R., McQuaid, J.R., Chalekian, J., & Granholm, E. (2006). Integrated cognitive behavioral therapy versus 9

10 twelve-step facilitation for substance dependent adults with depressive disorders. Journal of Psychoactive Drugs, 38(4): Glasner-Edwards, S.V., Tate, S.R., McQuaid, J.R., Cummins, K., Granholm, E., & Brown, S.A. (2007). Mechanisms of action in integrated cognitive behavioral treatment versus 12-Step facilitation for substance dependent adults with comorbid major depression. Journal of Studies on Alcohol and Drugs, 68(5): Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2008). Risk factors for suicide attempts in methamphetamine dependent patients. American Journal on Addictions, 17(1): Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2008). Identifying methamphetamine users at risk for major depressive disorder: findings from the Methamphetamine Treatment Project at 3-year follow-up. American Journal on Addictions, 17: Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2008). Clinical course and outcomes of methamphetamine-dependent adults with psychosis. Journal of Substance Abuse Treatment, 35: Glasner-Edwards, S., Marinelli-Casey, P., Gonzales, R., Hillhouse, M., et al. (2009). Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year followup. Journal of Nervous & Mental Disease, 197: Mooney, L.J., Glasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Ang, A., Hunter, J., Haning, W., Colescott, P., Ling, W., & Rawson, R.A. (2009). Health conditions in methamphetamine-dependent adults 3 years after treatment. Journal of Addiction Medicine, 3(3): Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2010). Psychopathology in methamphetaminedependent adults 3 years after treatment. Drug and Alcohol Review, 29: Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2010). Anxiety disorders among methamphetamine dependent adults: association with posttreatment outcomes. American Journal on Addictions, 19(5):

11 12. Glasner-Edwards, S., & Rawson, R.A. (2010). Evidence-based practices in addiction treatment: review and recommendations for public policy. Health Policy, 97: Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2011). Bulimia nervosa among methamphetamine dependent adults: association with outcomes 3 years after treatment. Eating Disorders: The Journal of Treatment and Prevention, 19(3): Glasner-Edwards, S., Mooney, L.J., Ang, A., Hillhouse, M., & Rawson, R.A. (2013). Does post-traumatic stress disorder affect post-treatment methamphetamine use? Journal of Dual Diagnosis, 9(2): Glasner-Edwards S, Mooney LJ. (2014) Methamphetamine psychosis: epidemiology and management. CNS Drugs, 28(12): Hartwell, E.E., Bujarski, S., Glasner-Edwards, S., & Ray, L.A. (2015). The association of alcohol severity and sleep quality in problem alcohol users. Alcohol and Alcoholism. 17. Glasner-Edwards, S., Patrick, K., Ybarra, M., Garneau, H.C., Chavez, K., Venegas, A., & Rawson, R.A. (in press). A cognitive behavioral therapy based text messaging intervention versus medical management for HIVinfected substance users: study protocol for a pilot randomized trial. Journal of Medical & Internet Research. 18. Glasner-Edwards, S., Mooney, L., Ang, A., Garneau, H.C., Hartwell, E., Brecht, L., & Rawson, R.A. (in press). Mindfulness based relapse prevention for stimulant dependent adults: a pilot randomized clinical trial. Mindfulness. RESEARCH PAPERS - PEER REVIEWED (SUBMITTED) 1. Hartwell, E., Moallem, N.R., Courtney, K.E., Glasner-Edwards, S., & Ray, L. (under review). Gender differences in the association between internalizing symptoms and craving in methamphetamine users. Journal of Addiction Medicine. RESEARCH PAPERS NON-PEER REVIEWED 1. Gavriel, M., Glasner-Edwards, S., & Sackler, H. (2008). Response: Innovations and implementation. Addiction Science & Clinical Practice, 4(2), CHAPTERS 1. Glasner, S.V. (2004). Motivation and addiction: the role of incentive processes in understanding and treating addictive disorders. In: W.M. Cox & 11

12 BOOKS E. Klinger (Eds.), Handbook of Motivational Counseling. England: Wiley & Sons. 2. Pechnick, R.N., Glasner, S.V., & Wilkins, J. (2007). Hallucinogens. In: Gabbard, G.O. (Ed.), Treatments of Psychiatric Disorders: Fourth Edition (pp ). Washington, DC: American Psychiatric Publishing. 3. Mooney, L.J., Glasner-Edwards, S., Rawson, R.A., & Ling, W.L. (2009). Medical consequences of methamphetamine use. In: Roll, J.M., Rawson, R.A., Ling, W., & Shoptaw, S. (Eds.), Methamphetamine Addiction. New York, NY: Guilford Press. 4. Glasner-Edwards, S. Motivational interventions for substance abusers with psychiatric illness. (2011). In: W.M. Cox & E. Klinger (Eds.), Handbook of Motivational Counseling: Second Edition. England: Wiley & Sons, pp Glasner-Edwards (2015). The Addiction Recovery Skills Workbook. New Harbinger: Oakland, CA. REVIEWS 1. Pechnick, R., Glasner-Edwards, S., Wilkins, J. (2007). Preclinical development and clinical implementation of treatments for substance abuse disorders. FOCUS, 5(2): Glasner-Edwards, S. (2011). Review of Assessing Mindfulness and Acceptance Processes in Clients: Illuminating the Theory and Practice of Change, by Ruth Baer. Drug and Alcohol Review, 30(1): 112. PAPERS IN PREPARATION (RESEARCH COMPLETED) 1. Glasner-Edwards, S., Kay-Lambkin, F., & Budney, A. Preliminary outcomes of a computerized intervention for depressed cannabis users in psychiatric care. 2. Glasner-Edwards, S., Patrick, K., Ybarra, M., Garneau, H.C., Chavez, K., Venegas, A., & Rawson, R.A. CBT delivered via text messaging improves antiretroviral therapy adherence and reduces drug use among HIV+ substance users. 3. Glasner-Edwards, S., Patrick, K., Ybarra, M., Garneau, H.C., Chavez, K., Venegas, A., & Rawson, R.A. Preliminary efficacy of CBT targeting alcohol use and antiretroviral therapy adherence. ABSTRACTS 1. Glasner, S.V., Abrams, K. & Kushner, M.G. (1999, November). Personality correlates of alcohol use among subjects with panic disorder and social 12

13 phobia: a comparative study. Paper presented at the annual meeting of the Association for the Advancement of Behavior Therapy (Toronto, Canada). 2. Glasner, S.V., Cox, W.M., Klinger, E., & Parish, C. (2001). Motivational structure as a predictor of post-treatment drinking in a male alcoholic sample. Abstracted in Journal of Addictive Diseases, 20(2): Glasner, S.V. (2001, May). Instrumental outcome revaluation induced by priming non-dependent rats with ethanol. Paper presented at the meeting of Mind and Emotion (Minneapolis, Minnesota). 4. Glasner, S.V., Overmier, J.B. & Balleine, B.W. (2001). The effects of ethanol priming on ethanol-seeking behavior in dependent and non-dependent rats. Abstracted in Alcoholism: Clinical & Experimental Research, 25(5): 65A Glasner, S.V., Tate, S.R., Mcquaid, J.R., Chalekian, J., Granholm, E., & Brown, S.A. (2004). Clinical trajectories of dually diagnosed individuals with depression and substance dependence in integrated treatment versus standard care: preliminary results of a randomized clinical trial. Abstracted in Alcoholism: Clinical & Experimental Research,28(5): 27A. 6. Glasner, S.V., Tate, S.R., McQuaid, J.R., Cummins, K., & Brown, S.A. (2006, June). Process changes in integrated cognitive behavioral treatment versus twelve-step facilitation for substance dependent adults with comorbid major depression. Paper presented at the 29 th annual meeting of the Research Society on Alcoholism (Baltimore, Maryland). 7. Glasner, S.V., Mooney, L.J., & Wilkins, J. (2006, June). Review of antidepressant treatment of methamphetamine dependence: hypothesized mechanisms and future directions. Paper presented at the 68 th annual meeting of the College on Problems of Drug Dependence (Scottsdale, Arizona). 8. Glasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Gonzales, R., Ang, A., Marcu, F., & Rawson, R.A. (2007, June). Psychiatric illness as a predictor of post-treatment methamphetamine use. Paper presented at the 69 th annual meeting of the College on Problems of Drug Dependence (Quebec City, Canada). 9. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2007, November). Clinical course of depression in methamphetamine users: association with clinical outcomes 3 years after treatment. Paper presented at the 18 th annual meeting of the American Academy of Addiction Psychiatry (San Diego, California). 13

14 10. Mooney, L.J., Glasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2007, November). Predictors of depression and suicide attempts in methamphetamine dependent patients. Paper presented at the 18 th Annual Meeting of the American Academy of Addiction Psychiatry (San Diego, CA) Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2008, June). Treatment outcomes of methamphetamine dependent adults with psychotic disorders. Paper presented at the 70 th annual meeting of the College on Problems of Drug Dependence (San Juan, Puerto Rico). 12. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2009, June). Effects of psychosocial treatment dose on outcomes in stimulant dependent adults. Paper presented at the 71 st annual meeting of the College on Problems of Drug Dependence (Reno, Nevada). 13. Mooney, L.J., Glasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Ang, A., Hunter, J., Haning, W., Colescott, P. & Rawson, R.A. (2009, June). Health conditions in methamphetamine-dependent adults 3 years after treatment. Paper presented at the 71 st annual meeting of the College on Problems of Drug Dependence (Reno, Nevada). 14. Glasner-Edwards, S., & Rawson, R.A. (2009, October). Evidence-based practices in addiction treatment. Paper presented at the annual meeting of Addiction Health Services Research (San Francisco, California). 15. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2010, June). Treatment outcomes of methamphetamine-dependent adults with anxiety disorders. Paper presented at the 72 nd annual meeting of the College on Problems of Drug Dependence (Scottsdale, Arizona). 16. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang. A., & Rawson, R.A. (2010, August). Treatment outcomes of methamphetamine users with mood and anxiety disorders. Paper presented at the 118 th annual meeting of the American Psychological Association (San Diego, CA). 17. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2011, June). Association of bulimia nervosa with treatment outcomes of methamphetamine dependent adults. Paper presented at the 73 rd annual meeting of the College on Problems of Drug Dependence (Orlando, FL). 14

15 18. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2012, June). Association of post-traumatic stress disorder with post-treatment outcomes of methamphetamine dependent adults. Paper presented at the 74 th annual meeting of the College on Problems of Drug Dependence (Palm Desert, CA). 19. Glasner-Edwards, S., Brown, S.A., & Rawson, R.A. (2012, November). Integrated CBT and motivational therapy versus community 12-step participation as continuing care for substance dependent adults with major depression. Paper presented at the 46 th annual meeting of the Association of Behavior and Cognitive Therapy (National Harbor, MD). 20. Glasner-Edwards, S., Brecht, L., Garneau, H.C., Lee, A.B., Brown, S.A., & Rawson, R.A. (2013, June). Association of cognitive functioning with treatment outcomes of substance dependent adults with major depression. Paper presented at the 75 th annual meeting of the College on Problems of Drug Dependence (San Diego, CA). 21. Glasner-Edwards, S., & Rawson, R.A. (2013, August). Development of a text messaging intervention for HIV+ drug users. Paper presented at the 121 st annual meeting of the American Psychological Association (Honolulu, HI). 22. Glasner-Edwards, S., Karno, M., Rawson, R.A., & Grella, C. (2013, October). Screening, brief intervention, and referral to treatment for substance abusers in mental health settings. Paper presented at the annual meeting of Addiction Health Services Research (Portland, OR). 23. Glasner-Edwards, S. (2015, June). Mobile phone technology targeting relapse prevention and medication adherence among HIV+ substance users. Paper presented at the 77 th annual meeting of the College on Problems of Drug Dependence (Phoenix, Arizona). 24. Glasner-Edwards, S., Mooney, L., Ang, A., Garneau, H.C., Hartwell, E., Brecht, L., & Rawson, R.A. (2015, June). Mindfulness-based relapse prevention improves stimulant use among stimulant dependent adults with major depression and generalized anxiety disorder. Paper presented at the 77 th annual meeting of the College on Problems of Drug Dependence (Phoenix, Arizona). 25. Spear, S.E., Karno, M., Glasner-Edwards, S., Saitz, R., Dominguez, B.X., Grella, C., Mooney, L.J., & Rawson, R.A. (2015, June). Applying SBIRT to new settings: findings of substance use disorder risk in community mental health settings. Paper presented at the 77 th annual meeting of the College on Problems of Drug Dependence (Phoenix, Arizona). 15

16 26. Glasner-Edwards, S. (2015, August). Development of a text messaging intervention for HIV+ alcohol users. Paper presented at the 123 rd annual meeting of the American Psychological Association (Toronto, Canada). 27. Garneau, H.C., Lee, A.B., Novoa, V., Veliz, R., Rawson, R.A., & Glasner- Edwards, S. (2015, August). Barriers to antiretroviral treatment adherence and initiation of addiction pharmacotherapy among HIV+ adults with alcohol use disorders. Paper presented at the 123 rd annual meeting of the American Psychological Association (Toronto, Canada). 28. Glasner-Edwards, S. (2015, October). Preliminary outcomes of a CBTbased text messaging intervention for HIV+ drug users. Paper presented at the annual meeting of Addiction Health Services Research (Culver City, CA). 16